98 related articles for article (PubMed ID: 11099833)
1. Evidence for existence of immobilization stress-inducible semicarbazide-sensitive amine oxidase inhibitor in rat brain cytosol.
Obata T; Yamanaka Y
Neurosci Lett; 2000 Dec; 296(1):58-60. PubMed ID: 11099833
[TBL] [Abstract][Full Text] [Related]
2. Endogenous semicarbazide-sensitive amine oxidase (SSAO) inhibitor increases 1-methyl-4-phenylpyridinium ion (MPP+)-induced dopamine efflux by immobilization stress in rat striatum.
Obata T
Int J Dev Neurosci; 2006 Aug; 24(5):343-7. PubMed ID: 16725303
[TBL] [Abstract][Full Text] [Related]
3. Evidence for existence of thyroid hormone inducible semicarbazide-sensitive amine oxidase (SSAO) in rat heart cytosol.
Obata T; Nakashima M
Indian Heart J; 2016; 68(2):225-30. PubMed ID: 27133345
[TBL] [Abstract][Full Text] [Related]
4. Immobilization stress increases endogenous monoamine oxidase (MAO) inhibitor in rat liver.
Obata T
Bioelectrochemistry; 2007 May; 70(2):308-10. PubMed ID: 16797252
[TBL] [Abstract][Full Text] [Related]
5. Semicarbazide-sensitive amine oxidase (SSAO) in the brain.
Obata T
Neurochem Res; 2002 Apr; 27(4):263-8. PubMed ID: 11958526
[TBL] [Abstract][Full Text] [Related]
6. 2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase.
Kinemuchi H; Jinbo M; Tabata A; Toyoshima Y; Arai Y; Tadano T; Kisara K; Oreland L
Jpn J Pharmacol; 2000 Jun; 83(2):164-6. PubMed ID: 10928332
[TBL] [Abstract][Full Text] [Related]
7. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
8. 2-bromoethylamine, a suicide inhibitor of semicarbazide-sensitive amine oxidase, increases hydralazine hypotension in rats.
Vidrio H; Medina M
J Cardiovasc Pharmacol; 2005 Sep; 46(3):316-24. PubMed ID: 16116337
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
11. The interaction of hydralazine with a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Its use as a radioactive ligand for the enzyme.
Barrand MA; Callingham BA
Biochem J; 1985 Dec; 232(2):415-23. PubMed ID: 4091799
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.
Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L
Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
15. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of tissue-bound semicarbazide-sensitive amine oxidase (SSAO) in guinea pig tissues.
Kobayashi N; Takahashi K; Takayanagi K; Takahashi K; Masuko S; Tadano T; Kisara K; Kinemuchi H
Life Sci; 2002 Feb; 70(13):1519-31. PubMed ID: 11895103
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
18. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition.
Ucar G; Topaloglu E; Burak Kandilci H; Gumusel B
Life Sci; 2005 Dec; 78(4):421-7. PubMed ID: 16111719
[TBL] [Abstract][Full Text] [Related]
19. Effect of antidepressant drug on semicarbazide-sensitive amine oxidase (SSAO) in dog brain.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):3-12. PubMed ID: 22032087
[TBL] [Abstract][Full Text] [Related]
20. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
Yu PH; Davis BA; Deng Y
Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
